Molecular analysis of hepatitis C virus infection in Bulgarian injecting drug users

Massimo Ciccozzi1, Gianni Zehender, Valeria Cento

  • 1Department of Infectious, Parasitic and Immunomediated Disease, Istituto Superiore di Sanita', Rome, Italy.

Insights

Hepatitis C virus (HCV) genotype 3a is most common among Bulgarian intravenous drug users. Molecular clock analysis reveals the HCV epidemic in Bulgaria began around 1960, with significant growth until the 2000s.

Area of Science:

  • Epidemiology
  • Virology
  • Molecular Biology

Background:

  • Intravenous drug users (IDUs) are at high risk for Hepatitis C virus (HCV) infection.
  • Limited data exists on HCV molecular epidemiology in Bulgaria, despite rising incidence among IDUs.
  • Two-thirds of infected Bulgarian IDUs develop chronic HCV infection.

Purpose of the Study:

  • To determine the prevalence of HCV genotypes among Bulgarian IDUs.
  • To investigate the evolutionary history and transmission dynamics of HCV in Bulgaria using molecular methods.

Main Methods:

  • Sequencing of the NS5B gene of the HCV virus.
  • Phylogenetic analysis using molecular clock and Bayesian inference methods.

Main Results:

  • Hepatitis C virus (HCV) genotype 3a was the predominant strain among Bulgarian IDUs.
  • Bayesian phylogenetic analysis dated the origin of the Bulgarian HCV 3a clade to 1960.
  • The HCV epidemic in Bulgaria experienced exponential growth from the 1960s to the 1990s, plateauing in the 2000s.

Conclusions:

  • HCV genotype 3a is the primary circulating strain among Bulgarian IDUs.
  • The findings provide insights into the historical spread and evolution of HCV in Bulgaria.
  • The observed epidemic plateau may suggest the impact of public health interventions in Bulgaria.